Drug development platform
MAH platform
Registration consultation
Strategic planning for drug development in enterprises
About Us
Guangzhou Michelangel Biomedical Research Institute Co., Ltd.
was established in September 2019. The company is based on Guangdong Nanshan Pharmaceutical Innovation Research Institute and the Yangtze River Delta Pharmaceutical Advanced Research Institute of the Shanghai Institute of Pharmacy, Chinese Academy of Sciences. It has formed joint alliances with multiple domestic and foreign pharmaceutical technology research and development institutions, universities, and pharmaceutical...
Latest News
04 / 2023-05
21 venture capital research | biomedical investmen...
04 / 2023-05
Brokerage research hot pharmaceutical industry att...
04 / 2023-05
The pharmaceutical and biological industry was bro...
Last year, the total scale of Shanghai's
Focusing on key fields such as integrated circuits, artificial intelligence, and biomedicine, what i...
Will Silicon Valley's bank collapse caus
The collapse of Silicon Valley Bank (SVB) caused a global sensation.As of March 12, 325 venture capi...